Novel scoring system using postoperative cardiopulmonary exercise testing predicts future explantation of left ventricular assist device

Circulation Journal

Volumn 79, Issue 3, 2015, Pages 560-566

  Imamura, Teruhiko ^a   Kinugawa, Koichiro ^a   Nitta, Daisuke ^a   Fujino, Takeo ^a   Inaba, Toshiro ^a   Maki, Hisataka ^a   Hatano, Masaru ^a   Kinoshita, Osamu ^a   Nawata, Kan ^a   Kyo, Shunei ^a   Ono, Minoru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Oxygen consumption; Predictor; Reverse remodeling; Ventricular assist device

Indexed keywords

BISOPROLOL; CARBON DIOXIDE; CARVEDILOL; ENALAPRIL; EPLERENONE; SPIRONOLACTONE;

ADULT; AGE; AIR CONDITIONING; AORTA VALVE; AREA UNDER THE CURVE; ARTICLE; BICYCLE ERGOMETER; BODY HEIGHT; BODY WEIGHT; BORG SCALE; BREATH ANALYSIS; CARDIOPULMONARY EXERCISE TEST; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; EXPIRATORY FLOW; EXPLANTATION SCORE; FATIGUE; FEMALE; FOLLOW UP; GENDER; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HUMAN; IMPLANTATION; LABORATORY TEST; LEFT VENTRICULAR ASSIST DEVICE; MALE; OXYGEN CONSUMPTION; PULMONARY ARTERY OCCLUSION PRESSURE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SURVIVAL; WEANING; CLINICAL TRIAL; EXERCISE TEST; HEART ASSIST DEVICE; HEART FAILURE; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED;

EID: 84923444482     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1058     Document Type: Article

References (26)

1. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med 1998; 339: 1522–1533.
2. Imamura T, Kinugawa K, Hatano M, Fujino T, Inaba T, Maki H, et al. Status 2 patients had poor prognosis without mechanical circulatory support. Circ J 2014; 78: 1396–1404.
3. Imamura T, Kinugawa K, Kato N, Muraoka H, Fujino T, Inaba T, et al. Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device. Circ J 2014; 78: 625–633.
4. Imamura T, Kinugawa K, Hatano M, Fujino T, Inaba T, Maki H, et al. Low cardiac output stimulates vasopressin release in patients with stage D heart failure. Circ J 2014; 78: 2259–2267.
5. Imamura T, Kinugawa K, Shiga T, Endo M, Kato N, Inaba T, et al. Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device. Circ J 2013; 77: 96–104.
6. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435–1443.
7. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998; 98: 2383–2389.
8. Simon MA, Kormos RL, Murali S, Nair P, Heffernan M, Gorcsan J, et al. Myocardial recovery using ventricular assist devices: Prevalence, clinical characteristics, and outcomes. Circulation 2005; 112(9 Suppl): I32–I36.
9. Simon MA, Primack BA, Teuteberg J, Kormos RL, Bermudez C, Toyoda Y, et al. Left ventricular remodeling and myocardial recovery on mechanical circulatory support. J Card Fail 2010; 16: 99–105.
10. Matsumiya G, Monta O, Fukushima N, Sawa Y, Funatsu T, Toda K, et al. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy? J Thorac Cardiovasc Surg 2005; 130: 699–704.
11. Dandel M, Weng Y, Siniawski H, Stepanenko A, Krabatsch T, Potapov E, et al. Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: Criteria for weaning from ventricular assist devices. Eur Heart J 2011; 32: 1148–1160.
12. Mano A, Nakatani T, Oda N, Kato T, Niwaya K, Tagusari O, et al. Which factors predict the recovery of natural heart function after insertion of a left ventricular assist system? J Heart Lung Transplant 2008; 27: 869–874.
13. Zafeiridis A, Jeevanandam V, Houser SR, Margulies KB. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 1998; 98: 656–662.
14. Imamura T, Kinugawa K, Hatano M, Fujino T, Muraoka H, Inaba T, et al. Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery. J Artif Organs 2014; 17: 23–32.
15. Hori M, Nagai R, Izumi T, Matsuzaki M. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: Results of the randomized, controlled, doubleblind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study. Heart Vessels 2014; 29: 238–247.
16. Hatano M, Kinugawa K, Shiga T, Kato N, Endo M, Hisagi M, et al. Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J 2011; 75: 1147–1155.
17. Itoh H, Ajisaka R, Koike A, Makita S, Omiya K, Kato Y, et al. Heart rate and blood pressure response to ramp exercise and exercise capacity in relation to age, gender, and mode of exercise in a healthy population. J Cardiol 2013; 61: 71–78.
18. Fujimoto N, Borlaug BA, Lewis GD, Hastings JL, Shafer KM, Bhella PS, et al. Hemodynamic responses to rapid saline loading: The impact of age, sex, and heart failure. Circulation 2013; 127: 55–62.
19. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, et al. Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: Insights into cardiac recovery. J Am Coll Cardiol 2013; 61: 1985–1994.
20. Kato TS, Chokshi A, Singh P, Khawaja T, Cheema F, Akashi H, et al. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail 2011; 4: 546–553.
21. Leibner ES, Cysyk J, Eleuteri K, El-Banayosy A, Boehmer JP, Pae WE. Changes in the functional status measures of heart failure patients with mechanical assist devices. ASAIO J 2013; 59: 117–122.
22. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006; 355: 1873–1884.
23. Yoshioka D, Sakaguchi T, Saito S, Miyagawa S, Nishi H, Yoshikawa Y, et al. Initial experience of conversion of Toyobo paracorporeal left ventricular assist device to DuraHeart left ventricular assist device. Circ J 2012; 76: 372–376.
24. Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician’s guide to cardiopulmonary exercise testing in adults: A scientific statement from the American Heart Association. Circulation 2010; 122: 191–225.
25. Khawaja T, Chokshi A, Ji R, Kato TS, Xu K, Zizola C, et al. Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure. J Cachexia Sarcopenia Muscle 2014; 5: 297–305.
26. Saito S, Yamazaki K, Nishinaka T, Ichihara Y, Ono M, Kyo S, et al. Post-approval study of a highly pulsed, low-shear-rate, continuousflow, left ventricular assist device, EVAHEART: A Japanese multicenter study using J-MACS. J Heart Lung Transplant 2014; 33: 599–608.